BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 18755807)

  • 1. Resveratrol alleviates alcoholic fatty liver in mice.
    Ajmo JM; Liang X; Rogers CQ; Pennock B; You M
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G833-42. PubMed ID: 18755807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
    Shen Z; Liang X; Rogers CQ; Rideout D; You M
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G364-74. PubMed ID: 20007851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
    You M; Liang X; Ajmo JM; Ness GC
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G892-8. PubMed ID: 18239056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
    Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
    J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and alcoholic fatty liver disease.
    Rogers CQ; Ajmo JM; You M
    IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
    Alberdi G; Rodríguez VM; Macarulla MT; Miranda J; Churruca I; Portillo MP
    Nutrition; 2013 Mar; 29(3):562-7. PubMed ID: 23274094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.
    Yang W; Huang L; Gao J; Wen S; Tai Y; Chen M; Huang Z; Liu R; Tang C; Li J
    Mol Med Rep; 2017 Oct; 16(4):5225-5234. PubMed ID: 28849079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adiponectin-SIRT1-AMPK pathway in alcoholic fatty liver disease in the rat.
    Jiang Z; Zhou J; Zhou D; Zhu Z; Sun L; Nanji AA
    Alcohol Clin Exp Res; 2015 Mar; 39(3):424-33. PubMed ID: 25703252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
    Kim MY; Lim JH; Youn HH; Hong YA; Yang KS; Park HS; Chung S; Ko SH; Shin SJ; Choi BS; Kim HW; Kim YS; Lee JH; Chang YS; Park CW
    Diabetologia; 2013 Jan; 56(1):204-17. PubMed ID: 23090186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.
    Iwabu M; Yamauchi T; Okada-Iwabu M; Sato K; Nakagawa T; Funata M; Yamaguchi M; Namiki S; Nakayama R; Tabata M; Ogata H; Kubota N; Takamoto I; Hayashi YK; Yamauchi N; Waki H; Fukayama M; Nishino I; Tokuyama K; Ueki K; Oike Y; Ishii S; Hirose K; Shimizu T; Touhara K; Kadowaki T
    Nature; 2010 Apr; 464(7293):1313-9. PubMed ID: 20357764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-
    Reyes-Gordillo K; Shah R; Varatharajalu R; Garige M; Leckey LC; Lakshman MR
    Oxid Med Cell Longev; 2016; 2016():1840513. PubMed ID: 28074114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
    Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
    Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
    [No Abstract]   [Full Text] [Related]  

  • 15. Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway.
    Bai T; Yang Y; Yao YL; Sun P; Lian LH; Wu YL; Nan JX
    Pharmacol Res; 2016 Mar; 105():1-12. PubMed ID: 26776965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein activated adenosine 5'-monophosphate-activated protein kinase-sirtuin1/peroxisome proliferator-activated receptor γ coactivator-1α pathway potentially through adiponectin and estrogen receptor β signaling to suppress fat deposition in broiler chickens.
    Jiang Z; Yang Z; Zhang H; Yao Y; Ma H
    Poult Sci; 2021 Jan; 100(1):246-255. PubMed ID: 33357687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.
    Huang B; Cheng X; Wang D; Peng M; Xue Z; Da Y; Zhang N; Yao Z; Li M; Xu A; Zhang R
    Oncotarget; 2014 Jul; 5(13):4732-45. PubMed ID: 25051362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice.
    You M; Cao Q; Liang X; Ajmo JM; Ness GC
    J Nutr; 2008 Mar; 138(3):497-501. PubMed ID: 18287356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin: a key adipokine in alcoholic fatty liver.
    You M; Rogers CQ
    Exp Biol Med (Maywood); 2009 Aug; 234(8):850-9. PubMed ID: 19491377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.